CVS Health Corporation
CVS
$95.89
-$1.26-1.30%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.15% | 8.40% | 7.76% | 8.35% | 6.92% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.15% | 8.40% | 7.76% | 8.35% | 6.92% |
| Cost of Revenue | 5.75% | 8.63% | 7.48% | 9.60% | 5.69% |
| Gross Profit | 8.46% | 6.83% | 9.71% | 0.90% | 14.61% |
| SG&A Expenses | 3.29% | 9.23% | 3.42% | 1.08% | 4.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.46% | 8.69% | 7.02% | 8.61% | 5.55% |
| Operating Income | 25.09% | -7.19% | 53.48% | 0.22% | 66.51% |
| Income Before Tax | 50.48% | -36.31% | -3,416.19% | -29.53% | 65.63% |
| Income Tax Expenses | 17.49% | -411.93% | 1,394.12% | 11.42% | 83.11% |
| Earnings from Continuing Operations | 65.94% | 80.10% | -5,719.72% | -42.70% | 58.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -366.67% | -4.76% | -6.25% | 300.00% | 72.73% |
| Net Income | 65.43% | 79.01% | -4,668.97% | -42.32% | 59.84% |
| EBIT | 25.09% | -7.19% | 53.48% | 0.22% | 66.51% |
| EBITDA | 17.70% | -4.37% | 29.21% | 0.67% | 42.73% |
| EPS Basic | 63.87% | 77.46% | -4,633.14% | -42.77% | 59.72% |
| Normalized Basic EPS | 27.55% | -19.67% | 61.80% | 2.56% | 76.94% |
| EPS Diluted | 63.12% | 76.56% | -4,633.14% | -43.23% | 60.23% |
| Normalized Diluted EPS | 27.26% | -19.98% | 61.80% | 2.48% | 77.52% |
| Average Basic Shares Outstanding | 0.95% | 0.87% | 0.79% | 0.80% | 0.08% |
| Average Diluted Shares Outstanding | 1.19% | 1.27% | 0.79% | 0.87% | -0.24% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.39% | -0.44% | -1.02% | 0.75% | -0.37% |